34 Initial results demonstrated immunogenicity of both vaccines but showed no significant survival differences between study arms 34 ; however, post-hoc analysis of long-term clinical outcomes revealed significantly improved OS and a favorable trend to improved RFS with melanoma-cognate helper peptide vaccination, with greatest benefit in males (Table 2 ). 35 These results provide support for designing a randomized phase III trial with melanoma helper peptide vaccination powered to detect differences in clinical outcome and highlights the need to study the impact of biologic sex on outcomes in vaccine trials.
← all phrases
“a favorable trend”
Sighted at
p=0.09
In the literature
Mean lean body mass showed a favorable trend of increment at week 6 (Δ 0.05 kg, 95% CI: −0.40, 0.49) and week 12 (Δ 0.16 kg, 95% CI: −0.33, 0.64) as compared to baseline in the intervention group but not in the control group which manifested decreasing lean body mass.
Overall, no significant difference was observed for Stage II patients; however, when limited to high-risk Stage II patients, a favorable trend was observed in the FOLFOX group (5-year DFS: FOLFOX group—82.3%; LV5FU2 group—74.6%; HR = 0.72).
In terms of cohort effects, incidence and mortality risks remained largely stable, while the cohort risk for DALY rates showed a significant decline, indicating a favorable trend.
A favorable trend in OS was indicated and consistent results were observed across all key subgroups (Figs. 4 , 5 ).
Although maternal adverse outcomes did not differ significantly between groups (13/30, 43% vs 11/30, 37%), a favorable trend was observed.
Despite the lack of significant difference, a favorable trend towards improved exercise capacity based on the 6MWD at 30 days was also observed ( Figure 5 ). 4.
Descriptive Statistics and Reliability Coefficients Table 1 shows that the mean scores of all variables present a favorable trend since they were higher than the theoretical mean (MT = 4.00).
Despite a favorable trend, the benefit of postoperative chemotherapy on overall survival has not been shown to be significant.
Moreover, interventions involving aerobic exercise and dietary restriction seemed to show a favorable trend concerning to WM. 4.1.
Although the interim OS analysis was not statistically significant in the ITT population, a favorable trend in overall survival was also observed in the BRCA wild-type, HRD-positive population.
At the end of the 20th century, men in Poland consumed an average of 332 g of meat and its products per day, and women consumed 175 g/day, which indicates the existence of a favorable trend.
The results suggest a continuing decline in the global burden of KC among both males and females, indicating a favorable trend (Fig. 5 ).
23 , 24 As a favorable trend, we showed improved survival rates over time, especially for patients with ISTAF, which supports our previous findings in the same cohort demonstrating a decrease in mortality in all patients with AF 25 and large epidemiological studies showing improved stroke survival rates during the past decade.
While some studies have reported an increased rate of infection in older patients, others have observed a favorable trend with increasing age.
23 To the best of our knowledge, our study is the first to demonstrate a statistically significant improvement in outcomes associated with VCR versus CBCR coupled with a favorable trend in overall health care costs among patients participating in VCR.
We found modest differences in timing of outcomes among patients monitored with real‐time results (non‐Holter), compared with those using traditional Holter test—in general and contrary to expected, real‐time ambulatory monitoring patients did not undergo cardiac procedures sooner and did not present to emergency department or hospitalization sooner, though there was a favorable trend toward earlier initiation of oral anticoagulation among patients with real‐time monitoring.
However, the stroke reduction effect was not statistically significant, though it showed a favorable trend (RR 0.76–0.47 to 1.24).
Neflamapimod (target class: inflammation), a p38α kinase inhibitor, demonstrated a favorable trend for NRGN and decreased CSF levels of pTau181 and tTau in comparison to a placebo.
Although the predefined clinical significance criteria were not fully met, the program demonstrated a favorable trend toward improved efficiency and patient-centered care.
Although statistical significance was not reached for some outcomes, this analysis showed a favorable trend for the ESD technique.
The analysis showed a difference in treatment effect between participants with and without previous MI, with a favorable trend for the effect in TM vs.
Sweden has a favorable trend typical of countries with high SDI, with a decline in mortality among older adults aged 64–94 years in all age groups, as well as declining and low stable age, period and cohort risk.
Other efficacy endpoints While there were no significant LI + CIZ + SOC advantages over SOC alone for PFS and LRC in the overall population, a favorable trend was observed for the ITT LR group in the case of the PFS ( Supplementary Figure S6 ), with a hazard ratio of 0.76 (95% CI: 0.55–1.04).
24 In this study, the IC 50 response showed a favorable trend with a coating conjugate concentration of 2.5 μg/mL compared to the highest concentration at 5.0 μg/mL and the lowest concentration at 0.625 μg/mL.